← Back to Search

Jumpstart Guide for Dementia Care Planning (PICSI-M Trial)

N/A
Recruiting
Led By Erin Kross, MD
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
55 years of age or older
18 years of age or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days following randomization
Awards & highlights

PICSI-M Trial Summary

This trial is testing a way to help clinicians have better conversations with patients and their families to address healthcare goals. It uses a simple guide called the "Jumpstart Guide" to do this.

Who is the study for?
This trial is for patients aged 55+ with memory issues and chronic conditions like cancer, heart failure, or diabetes. It's also for their caregivers who are involved in their care. Participants must speak English and be treated at a UW Medicine clinic. Clinicians from UW Medicine caring for these patients can join too.Check my eligibility
What is being tested?
Researchers are testing the 'Jumpstart Guide' to see if it helps clinicians discuss healthcare goals more effectively with patients having memory problems and their families. They'll compare outcomes between those using the guide and those not to measure its impact on communication.See study design
What are the potential side effects?
Since this trial involves communication tools rather than medical treatments, there aren't traditional side effects. However, participants may experience emotional or psychological impacts from discussing sensitive topics about healthcare goals.

PICSI-M Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 55 years old or older.
Select...
I am 18 years old or older.

PICSI-M Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days following randomization
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days following randomization for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
EHR documentation of Goals of Care discussions
Secondary outcome measures
Anxiety

PICSI-M Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Jumpstart GuideExperimental Treatment1 Intervention
The Jumpstart Guide is developed using automated methods. It summarizes the presence/absence of POLST, advance directives and DPOA documentation. The Jumpstart Guide also provides tips for conducting discussion about goals of care.
Group II: Usual CareActive Control1 Intervention
Clinicians of patients in the Usual Care arm will not receive a Jumpstart Guide.

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor
1,741 Previous Clinical Trials
1,846,566 Total Patients Enrolled
2 Trials studying Health Communication
3,130 Patients Enrolled for Health Communication
National Institute on Aging (NIA)NIH
1,675 Previous Clinical Trials
28,019,685 Total Patients Enrolled
4 Trials studying Health Communication
3,271 Patients Enrolled for Health Communication
Erin Kross, MDPrincipal InvestigatorUniversity of Washington

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is participation in this research endeavor currently available?

"Correct. Clinicaltrials.gov reveals that this medical trial is presently seeking participants, with the study having been first posted on September 11th of 2023 and updated recently on the same date."

Answered by AI

What is the current capacity for patient enrollment in this scientific investigation?

"Affirmative. Clinicaltrials.gov records indicate that this clinical trial, first published on the 11th of September 2023 is actively recruiting patients; 1200 in total from 3 distinct medical sites."

Answered by AI

Who else is applying?

What site did they apply to?
UW Medical Center
What portion of applicants met pre-screening criteria?
Met criteria

Why did patients apply to this trial?

~800 spots leftby Oct 2025